Neurim v Teva

Neurim v Teva [2022] EWHC 954 (Pat) – Edward acted for Teva in successfully resisting an application by Neurim and Flynn Pharma for an interim injunction to restrain Teva’s dealing in its generic prolonged-release Melatonin pharmaceutical product. Led by Charlotte May QC.